Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study
E. Lee (Seoul, Republic of Korea), T. Lee (Seoul, Republic of Korea), Y. Hong (Seoul, Republic of Korea), J. Ryoo (Seoul, Republic of Korea), J. Heo (Seoul, Republic of Korea), H. Kang (Seoul, Republic of Korea), S. Kwon (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea)
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Lee (Seoul, Republic of Korea), T. Lee (Seoul, Republic of Korea), Y. Hong (Seoul, Republic of Korea), J. Ryoo (Seoul, Republic of Korea), J. Heo (Seoul, Republic of Korea), H. Kang (Seoul, Republic of Korea), S. Kwon (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea). Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study. 478
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: